Featured Research

from universities, journals, and other organizations

Research demonstrates 'guided missile' strategy to kill hidden HIV

Date:
January 9, 2014
Source:
University of North Carolina School of Medicine
Summary:
Researchers have deployed a potential new weapon against HIV -- a combination therapy that targets HIV-infected cells that standard therapies cannot kill.

Scanning electron micrograph of HIV-1 virions budding from a cultured lymphocyte.
Credit: CDC/C. Goldsmith, P. Feorino, E. L. Palmer, W. R. McManus

Researchers at the UNC School of Medicine have deployed a potential new weapon against HIV -- a combination therapy that targets HIV-infected cells that standard therapies cannot kill.

Using mouse models that have immune systems composed of human cells, researchers led by J. Victor Garcia, PhD, found that an antibody combined with a bacterial toxin can penetrate HIV-infected cells and kill them even though standard antiretroviral therapy, also known as ART, had no effect. Killing these persistent, HIV-infected cells is a major impediment to curing patients of HIV.

"Our work provides evidence that HIV-infected cells can be tracked down and destroyed throughout the body," said Garcia, professor of medicine and senior author of the study published January 9 in the journal PloS Pathogens.

For people with HIV, ART is life-saving treatment that can reduce the amount of virus in the body to undetectable levels. But as soon as treatment is stopped, the virus begins to replicate again. This means that people with HIV must be on medications for life. For some people, therapies are not without serious side effects.

In patients on ART, the virus either remains dormant or it multiplies very slowly -- it persists, hidden, even though a cocktail of drugs is aligned against it.

Garcia's findings advance the so-called "kick-and-kill" strategy for HIV eradication -- if the persistent virus is exposed, it can be targeted and killed with a new therapy.

To attack persistent HIV-infected cells, Garcia and colleagues used humanized bone marrow/liver/thymus mice -- or BLT mice -- with entire immune systems composed of human cells. This allows his team to study the distribution of persistent HIV-infected cells throughout the body and test strategies to eliminate those cells.

For the PloS Pathogens study, the researchers first treated the mice with an ART cocktail of three different drugs. Despite using strong concentrations of all three drugs, the researchers found that the virus managed to survive in immune cells in all tissues they analyzed, including the bone marrow, spleen, liver, lung, and gut.

Then they used a compound developed by co-authors Edward Berger, PhD, and Ira Pastan, PhD, from the National Institute of Allergy and Infectious Diseases (part of the National Institutes of Health). The compound is an antibody called 3B3 combined with a bacterial toxin called PE38. The researchers hypothesized that the antibody would first recognize cells expressing a specific HIV protein on the surface of infected cells. The antibody would attach to the protein and allow the toxin to enter and kill the infected cells.

When Garcia's team treated humanized HIV-infected and ART-treated mice with the 3B3-PE38 compound and then looked for infected cells in tissues, they found that the molecular missile had killed the vast majority of persistent HIV-infected cells that had been actively producing the virus despite traditional therapy, resulting in a six-fold drop in the number of infected cells throughout the immune systems.

While this reduction fell short of complete eradication, the finding offers a new route of investigation as part of the multi-pronged "kick-and-kill" strategy.

"The BLT model represents a platform in which virtually any novel approach to HIV eradication can be tested," Garcia said. "It helps us prioritize which therapeutic approaches should be advanced to clinical implementation in humans. This study shows that it's possible to attack and kill hidden HIV-infected cells that standard therapy can't touch."


Story Source:

The above story is based on materials provided by University of North Carolina School of Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Paul W. Denton, Julie M. Long, Stephen W. Wietgrefe, Craig Sykes, Rae Ann Spagnuolo, Olivia D. Snyder, Katherine Perkey, Nancie M. Archin, Shailesh K. Choudhary, Kuo Yang, Michael G. Hudgens, Ira Pastan, Ashley T. Haase, Angela D. Kashuba, Edward A. Berger, David M. Margolis, J. Victor Garcia. Targeted Cytotoxic Therapy Kills Persisting HIV Infected Cells During ART. PLoS Pathogens, 2014; 10 (1): e1003872 DOI: 10.1371/journal.ppat.1003872

Cite This Page:

University of North Carolina School of Medicine. "Research demonstrates 'guided missile' strategy to kill hidden HIV." ScienceDaily. ScienceDaily, 9 January 2014. <www.sciencedaily.com/releases/2014/01/140109175449.htm>.
University of North Carolina School of Medicine. (2014, January 9). Research demonstrates 'guided missile' strategy to kill hidden HIV. ScienceDaily. Retrieved April 18, 2014 from www.sciencedaily.com/releases/2014/01/140109175449.htm
University of North Carolina School of Medicine. "Research demonstrates 'guided missile' strategy to kill hidden HIV." ScienceDaily. www.sciencedaily.com/releases/2014/01/140109175449.htm (accessed April 18, 2014).

Share This



More Health & Medicine News

Friday, April 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Scientists Create Stem Cells From Adult Skin Cells

Scientists Create Stem Cells From Adult Skin Cells

Newsy (Apr. 17, 2014) The breakthrough could mean a cure for some serious diseases and even the possibility of human cloning, but it's all still a way off. Video provided by Newsy
Powered by NewsLook.com
Obama: 8 Million Healthcare Signups

Obama: 8 Million Healthcare Signups

AP (Apr. 17, 2014) President Barack Obama gave a briefing Thursday announcing 8 million people have signed up under the Affordable Care Act. He blasted continued Republican efforts to repeal the law. (April 17) Video provided by AP
Powered by NewsLook.com
Is Apathy A Sign Of A Shrinking Brain?

Is Apathy A Sign Of A Shrinking Brain?

Newsy (Apr. 17, 2014) A recent study links apathetic feelings to a smaller brain. Researchers say the results indicate a need for apathy screening for at-risk seniors. Video provided by Newsy
Powered by NewsLook.com
Could Even Casual Marijuana Use Alter Your Brain?

Could Even Casual Marijuana Use Alter Your Brain?

Newsy (Apr. 16, 2014) A new study conducted by researchers at Northwestern and Harvard suggests even casual marijuana use can alter your brain. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins